AMRIF
PrivateCompany Overview
AMRIF is a biotechnology company that develops RESCAP, an alkaline phosphatase-based oral enzyme supplement intended for the treatment of chronic inflammatory and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biopharmaceuticalalkaline phosphataseRESCAPtherapeutic proteinschronic inflammatory diseasesbiotechdrug developmentclinical trialsrecombinant human enzymeage-related diseasesneurodegenerative diseasesenzyme therapytranslational researchdrug pipeline
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMRIF Comparables
Compare AMRIF with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alloksys Life Sciences B.V. | 80% | |
| Theriva Biologics | 71% | |
| AM-Pharma | 71% | |
AMRIF Funding Rounds
Historical fundraising activity
AMRIF Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AMRIF's valuation, stock price, and market status.
See something wrong or outdated?